13F Holdings
中文EN

AMTX AEMETIS, INC

Industrial Organic Chemicals · Nasdaq · SEC CIK 738214 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY23.6%
TTM net income YoY64.5%
TTM EPS YoY73.5%
Revenue 3-yr CAGR10.8%
Net income 3-yr CAGR—

Margins

Gross margin21.5%
Operating margin7.2%
Net margin-12.5%
FCF margin-14.7%
EBITDA margin11.3%

Returns

ROE—
ROA-11.3%
ROIC (approx.)17.5%
Asset turnover0.90x

Leverage & solvency

Liabilities / assets200.7%
Debt / equity—
Current ratio0.07x
Interest coverage0.32x

Cash quality & payout

Operating cash flow / net income-0.49x
Accruals ratio-16.8%
Payout ratio—
Capex / revenue20.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$197.63M$267.64M$186.72M$28.11M$211.95M
Cost of revenue$208.75M$268.22M$184.70M$262.05M$204.01M
Gross profit-$768,000-$580,000$2.02M-$5.54M$7.94M
R&D expense——$152,000$180,000$88,000
SG&A expense$36.45M$39.84M$39.42M$28.69M$23.68M
Operating income-$37.22M-$40.42M-$37.40M-$34.40M-$15.82M
Interest expense$52.91M$46.62M$39.52M$28.77M$24.06M
Pretax income-$95.75M-$98.37M-$100.16M-$106.70M-$47.27M
Income tax-$18.75M-$10.83M-$53.74M$1.05M-$128,000
Net income-$77.00M-$87.54M-$46.42M-$107.76M-$47.15M
EBITDA-$27.59M-$32.03M-$30.47M-$28.87M-$10.38M
EPS (basic)-1.28-1.91-1.22-3.12-1.54
EPS (diluted)-1.28-1.91-1.22-3.12-1.54
Weighted avg. shares (diluted)59.98M45.90M38.06M34.59M30.68M
Balance sheet
Cash & equivalents$4.89M$898,000$2.67M$4.31M$7.75M
Receivables———$1.26M$1.57M
Inventory$11.63M$25.44M$18.29M$4.66M$5.13M
Current assets$26.87M$44.70M$36.40M$18.14M$20.69M
PP&E, net$219.72M$199.39M$195.11M$180.44M$135.10M
Total assets$259.84M$259.30M$243.41M$207.11M$160.83M
Current liabilities$371.26M$143.97M$84.39M$88.28M$65.33M
Short-term debt$317.87M$90.53M$37.03M$49.22M$22.78M
Long-term debt$63.90M$247.53M$257.69M$197.02M$165.99M
Total debt$381.76M$338.06M$294.72M$246.24M$188.77M
Total liabilities$566.67M$523.23M$460.38M$408.97M$281.07M
Shareholders' equity-$306.83M-$263.93M-$216.98M-$201.85M-$120.24M
Net debt$376.87M$337.16M$292.05M$241.93M$181.02M
Shares outstanding66.19M51.14M40.97M35.87M33.46M
Cash flow statement
Operating cash flow$3.26M-$32.93M$13.82M-$22.87M-$20.65M
Capital expenditure$26.00M$20.25M$33.12M$39.16M$26.65M
Free cash flow-$22.74M-$53.18M-$19.29M-$62.02M-$47.30M
Investing cash flow-$25.59M-$14.15M-$23.69M-$31.31M-$22.89M
Financing cash flow$26.41M$44.62M$9.09M$53.63M$50.70M
Depreciation & amortization$9.62M$8.39M$6.93M$5.54M$5.45M
Stock-based compensation$5.77M$8.31M$7.66M$6.41M$3.93M

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.